FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033234989> ?p ?o ?g. }

• W2033234989 endingPage "774" @default.
• W2033234989 startingPage "770" @default.
• W2033234989 abstract "Estrogen receptor-negative breast carcinomas are more aggressive and are unresponsive to anti-estrogens. Thus, they clearly require new therapies targeted against specific genes and proteins actively engaged in the pathophysiology of cancer. The S-phase kinase-associated protein Skp2 is required for the ubiquitin-mediated degradation of the cdk-inhibitor p27 and is a bona fide proto-oncoprotein. We attempted to explore whether Skp2 may be a potential specific therapeutic target in the subset of aggressive breast carcinomas by investigating the possible relationship between expression of Skp2 and p27 proteins and estrogen receptor (ER). Immunohistochemical analysis of tumor tissues was employed to determine the expression of Skp2, p27, and ER proteins in 82 cases of primary breast carcinoma. Higher levels of Skp2 were detected more frequently in ER-negative tumors and tumors metastatic to the axillary lymph nodes. The expression of p27 was inverse with the histologic grade. Statistical analysis showed that the percentage of high Skp2 expressors was significantly greater in the group with low p27 expression than in the group with high p27 expression. The current study, together with the results from a previous study, demonstrated the existence of a subtype of high-grade, negative ER breast carcinomas with high Skp2 and low p27 levels. This implies that Skp2 may be a potential specific therapeutic target in a subset of aggressive breast carcinomas. Thus far, there is no specific therapy for the ER-negative and HER-2/neu resistant groups, which are among the subset of aggressive tumors." @default.
• W2033234989 created "2016-06-24" @default.
• W2033234989 creator A5005336248 @default.
• W2033234989 creator A5010055744 @default.
• W2033234989 creator A5041083223 @default.
• W2033234989 creator A5041724163 @default.
• W2033234989 creator A5049361494 @default.
• W2033234989 date "2005-10-01" @default.
• W2033234989 modified "2023-09-27" @default.
• W2033234989 title "Relationship between levels of Skp2 and P27 in breast carcinomas and possible role of Skp2 as targeted therapy" @default.
• W2033234989 cites W1558846872 @default.
• W2033234989 cites W1575711703 @default.
• W2033234989 cites W1965049479 @default.
• W2033234989 cites W1968441904 @default.
• W2033234989 cites W1987017349 @default.
• W2033234989 cites W2000196730 @default.
• W2033234989 cites W2010871781 @default.
• W2033234989 cites W2015066175 @default.
• W2033234989 cites W2018244552 @default.
• W2033234989 cites W2028135511 @default.
• W2033234989 cites W2056234356 @default.
• W2033234989 cites W2058873057 @default.
• W2033234989 cites W2060385362 @default.
• W2033234989 cites W2087897920 @default.
• W2033234989 cites W2088938912 @default.
• W2033234989 cites W2092104789 @default.
• W2033234989 cites W2106181427 @default.
• W2033234989 cites W2123697148 @default.
• W2033234989 cites W2131954674 @default.
• W2033234989 cites W2170083676 @default.
• W2033234989 doi "https://doi.org/10.1016/j.steroids.2005.04.012" @default.
• W2033234989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16024059" @default.
• W2033234989 hasPublicationYear "2005" @default.
• W2033234989 type Work @default.
• W2033234989 sameAs 2033234989 @default.
• W2033234989 citedByCount "32" @default.
• W2033234989 countsByYear W20332349892012 @default.
• W2033234989 countsByYear W20332349892013 @default.
• W2033234989 countsByYear W20332349892014 @default.
• W2033234989 countsByYear W20332349892016 @default.
• W2033234989 countsByYear W20332349892017 @default.
• W2033234989 countsByYear W20332349892019 @default.
• W2033234989 countsByYear W20332349892020 @default.
• W2033234989 countsByYear W20332349892021 @default.
• W2033234989 countsByYear W20332349892022 @default.
• W2033234989 countsByYear W20332349892023 @default.
• W2033234989 crossrefType "journal-article" @default.
• W2033234989 hasAuthorship W2033234989A5005336248 @default.
• W2033234989 hasAuthorship W2033234989A5010055744 @default.
• W2033234989 hasAuthorship W2033234989A5041083223 @default.
• W2033234989 hasAuthorship W2033234989A5041724163 @default.
• W2033234989 hasAuthorship W2033234989A5049361494 @default.
• W2033234989 hasConcept C104317684 @default.
• W2033234989 hasConcept C121608353 @default.
• W2033234989 hasConcept C126322002 @default.
• W2033234989 hasConcept C134459356 @default.
• W2033234989 hasConcept C204232928 @default.
• W2033234989 hasConcept C25602115 @default.
• W2033234989 hasConcept C2776787872 @default.
• W2033234989 hasConcept C2777164284 @default.
• W2033234989 hasConcept C2777546739 @default.
• W2033234989 hasConcept C2781230642 @default.
• W2033234989 hasConcept C3018521938 @default.
• W2033234989 hasConcept C502942594 @default.
• W2033234989 hasConcept C530470458 @default.
• W2033234989 hasConcept C55493867 @default.
• W2033234989 hasConcept C71924100 @default.
• W2033234989 hasConcept C84606932 @default.
• W2033234989 hasConcept C86803240 @default.
• W2033234989 hasConcept C98717036 @default.
• W2033234989 hasConceptScore W2033234989C104317684 @default.
• W2033234989 hasConceptScore W2033234989C121608353 @default.
• W2033234989 hasConceptScore W2033234989C126322002 @default.
• W2033234989 hasConceptScore W2033234989C134459356 @default.
• W2033234989 hasConceptScore W2033234989C204232928 @default.
• W2033234989 hasConceptScore W2033234989C25602115 @default.
• W2033234989 hasConceptScore W2033234989C2776787872 @default.
• W2033234989 hasConceptScore W2033234989C2777164284 @default.
• W2033234989 hasConceptScore W2033234989C2777546739 @default.
• W2033234989 hasConceptScore W2033234989C2781230642 @default.
• W2033234989 hasConceptScore W2033234989C3018521938 @default.
• W2033234989 hasConceptScore W2033234989C502942594 @default.
• W2033234989 hasConceptScore W2033234989C530470458 @default.
• W2033234989 hasConceptScore W2033234989C55493867 @default.
• W2033234989 hasConceptScore W2033234989C71924100 @default.
• W2033234989 hasConceptScore W2033234989C84606932 @default.
• W2033234989 hasConceptScore W2033234989C86803240 @default.
• W2033234989 hasConceptScore W2033234989C98717036 @default.
• W2033234989 hasIssue "11" @default.
• W2033234989 hasLocation W20332349891 @default.
• W2033234989 hasLocation W20332349892 @default.
• W2033234989 hasOpenAccess W2033234989 @default.
• W2033234989 hasPrimaryLocation W20332349891 @default.
• W2033234989 hasRelatedWork W1970614368 @default.
• W2033234989 hasRelatedWork W2033234989 @default.
• W2033234989 hasRelatedWork W2040740466 @default.
• W2033234989 hasRelatedWork W2337741472 @default.
• W2033234989 hasRelatedWork W2413773866 @default.

• next